These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27023495)

  • 21. Inhibition of human peptide deformylase disrupts mitochondrial function.
    Escobar-Alvarez S; Gardner J; Sheth A; Manfredi G; Yang G; Ouerfelli O; Heaney ML; Scheinberg DA
    Mol Cell Biol; 2010 Nov; 30(21):5099-109. PubMed ID: 20805355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive inhibition of alkaline phosphatase isozymes by thiazol-2-ylidene-benzamide derivatives: Functional insights into their anticancer role.
    Ejaz SA; Saeed A; Shah SJA; Hameed A; Lecka J; Sévigny J; Iqbal J
    J Cell Biochem; 2018 Aug; 119(8):6501-6513. PubMed ID: 29363794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biphenyl tetrazole-thiazolidinediones as novel bacterial peptide deformylase inhibitors: Synthesis, biological evaluations and molecular docking study.
    Khan FAK; Jadhav KS; Patil RH; Shinde DB; Arote RB; Sangshetti JN
    Biomed Pharmacother; 2016 Oct; 83():1146-1153. PubMed ID: 27551762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potent VHZ phosphatase inhibitors with structure-based virtual screening.
    Park H; Park SY; Oh JJ; Ryu SE
    J Biomol Screen; 2013 Feb; 18(2):226-31. PubMed ID: 23042075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.
    Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA
    Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and activity of human mitochondrial peptide deformylase, a novel cancer target.
    Escobar-Alvarez S; Goldgur Y; Yang G; Ouerfelli O; Li Y; Scheinberg DA
    J Mol Biol; 2009 Apr; 387(5):1211-28. PubMed ID: 19236878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of new erbB4 inhibitors: Repositioning an orphan chemical library by inverse virtual screening.
    Giordano A; Forte G; Massimo L; Riccio R; Bifulco G; Di Micco S
    Eur J Med Chem; 2018 May; 152():253-263. PubMed ID: 29730188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.
    Bai Y; Yu ZH; Zhang ZY
    Methods Mol Biol; 2016; 1447():121-38. PubMed ID: 27514804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Discovery of Antibacterial Natural Compound Based on Peptide Deformylase.
    Liang L; Zhou Q; Hao Z; Wang F; Zhu Y; Lin Q; Gao J
    Comb Chem High Throughput Screen; 2018; 21(4):292-297. PubMed ID: 29468960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells.
    Eirich J; Braig S; Schyschka L; Servatius P; Hoffmann J; Hecht S; Fulda S; Zahler S; Antes I; Kazmaier U; Sieber SA; Vollmar AM
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12960-5. PubMed ID: 25256790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights from ligand and structure based methods in virtual screening of selective Ni-peptide deformylase inhibitors.
    Ananthula RS; Ravikumar M; Mahmood SK; Kumar MN
    J Mol Model; 2012 Feb; 18(2):693-708. PubMed ID: 21562829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, in silico and in vitro evaluation of thiophene derivatives: A potent tyrosine phosphatase 1B inhibitor and anticancer activity.
    Gulipalli KC; Bodige S; Ravula P; Endoori S; Vanaja GR; Suresh Babu G; Narendra Sharath Chandra JN; Seelam N
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3558-3564. PubMed ID: 28579122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a series of small molecules as potent histone deacetylase inhibitors.
    Zhang L; Wang X; Li X; Xu W
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):333-7. PubMed ID: 23534931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of 4'-((5-benzylidene-2,4-dioxothiazolidin-3-yl)methyl)biphenyl-2-carbonitrile analogs as bacterial peptide deformylase inhibitors.
    Khan FA; Patil RH; Shinde DB; Sangshetti JN
    Chem Biol Drug Des; 2016 Dec; 88(6):938-944. PubMed ID: 27401234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).
    Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C
    Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based grafting and identification of kinase-inhibitors to target mTOR signaling pathway as potential therapeutics for glioblastoma.
    Cui YH; Chen J; Xu T; Tian HL
    Comput Biol Chem; 2015 Feb; 54():57-65. PubMed ID: 25625417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High throughput virtual screening (HTVS) of peptide library: Technological advancement in ligand discovery.
    Tripathi NM; Bandyopadhyay A
    Eur J Med Chem; 2022 Dec; 243():114766. PubMed ID: 36122548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.